Taurine Supplementation for Vascular and Orthostatic Function in Long COVID

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines if 12 weeks of self-administered taurine supplementation can improve resting vascular function and the body’s cardiovascular and cerebral responses during head-up tilt in individuals with Long COVID. Researchers will measure resting vascular function with EndoPAT, heart rate variability, and the blood pressure, heart rate, and brain blood flow during a 5-minute tilt test before and after supplementation. The goal is to see whether taurine can enhance vascular health and orthostatic tolerance, potentially reducing related symptoms. Participants are Long COVID patients who have had symptoms for at least 3 months, and the study is led by York University with CIHR collaboration.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants will have had symptoms of Long COVID post-infection for at least 3 months

Exclusion Criteria:

* Inability to undergo tilt table testing for 5 minutes
* Inability to transport selves to York University from their homes
* Inability to speak English, or provide a translator
* Blood clotting disorders

Where it's running

• York University
  Toronto, Ontario, Canada Recruiting

Study contacts

• Study coordinator: Heather Edgell, PhD
• Email: edgell@yorku.ca
• Phone: 14167362100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Micro-choice-based approach to fatigue management

  A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT07726082

• Immunoadsorption blood filter for autoimmune long COVID

  We will test a blood-filter treatment called immunoadsorption in people with long COVID who have specific autoantibodies to see if their fatigue and daily functioning get better.

  Recruiting Phase 2 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT07316127

• Anktiva for treating Long COVID symptoms

  This will test whether Anktiva helps adults aged 18–69 who had confirmed COVID-19 and now have persistent or worsened Long COVID symptoms.

  Recruiting Phase 2 ImmunityBio, Inc. · El Segundo, California · NCT07123727

• Magnetic resonance and rapid brain stimulation for Long COVID cognitive and mood symptoms

  This trial will test whether an accelerated outpatient magnetic brain stimulation (iTBS) can help reduce brain fog, depression, and anxiety in adults with Long COVID.

  Recruiting Phase 2 University of New Mexico · Albuquerque, New Mexico · NCT06940609

• Effects of Osteopathic Manipulative Therapy on Long COVID symptoms

  This study is testing whether Osteopathic Manipulative Therapy can help people with Long COVID feel better by reducing their symptoms over eight weeks.

  Recruiting University of Louisville · Louisville, Kentucky · NCT06883513

• Analyzing MicroRNAs and Vitamin B12 in Long COVID Patients with Neurological Symptoms

  This study is testing if changes in certain microRNAs and vitamin B12 levels in the blood can help understand and treat neurological symptoms like depression and fatigue in people who have long COVID.

  Recruiting Instituto Nacional de Rehabilitacion · Mexico City, Mexico City · NCT06864156

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.